Effect modification in network meta-analyses of treatments for relapsing refractory multiple myeloma (RRMM): systematic review, meta-analysis, and simulation

Christopher James Rose, Ingrid Kristine Ohm, Liv Giske, Gunn Eva Næss, Atle Fretheim
doi: https://doi.org/10.1101/2022.05.13.22275047

Article Information

doi 
https://doi.org/10.1101/2022.05.13.22275047
History 
  • May 20, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Christopher James Rose1,2,*,
  2. Ingrid Kristine Ohm1,
  3. Liv Giske1,
  4. Gunn Eva Næss1 and
  5. Atle Fretheim2
  1. 1Reviews and Health Technology Assessments, Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway
  2. 2Center for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway
  1. ↵*Corresponding author (cjro{at}fhi.no)
Back to top
Posted May 20, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Effect modification in network meta-analyses of treatments for relapsing refractory multiple myeloma (RRMM): systematic review, meta-analysis, and simulation
Christopher James Rose, Ingrid Kristine Ohm, Liv Giske, Gunn Eva Næss, Atle Fretheim
medRxiv 2022.05.13.22275047; doi: https://doi.org/10.1101/2022.05.13.22275047
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area